compounded semaglutide fda news New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect FDA Warns Against Using Compounded

When patients describe their experience with GLP-1 treatment, the word that comes up most often is "life-changing." One person with polycystic ovarian syndrome reported that nothing helped her insulin resistance until she started a GLP-1

TB-500 (Thymosin Beta-4 Acetate) is a synthetic 43-amino acid peptide derived from thymosin beta-4, a protein found in high concentrations in platelets, white blood cells, and wound fluid

Lipidomics: coming to grips with lipid diversity

We take reasonable and appropriate steps to ensure that third-party agents and service providers process your personal data in accordance with our Privacy Shield obligations and to stop and remediate any unauthorized processing